Measuring serum levels of glycosaminoglycans for prediction and using viscum fraxini-2 for treatment of patients with hepatocellular carcinoma

Measuring the disturbance of serum levels of GAGs and the elevation of their degradation enzymes may be of a value in the early diagnosis of HCC. Viscum fraxini-2 may have a role in the treatment of HCC and deserve further trials.